Repositioning Candidate Details
Candidate ID: | R1248 |
Source ID: | DB09218 |
Source Type: | experimental |
Compound Type: | small molecule |
Compound Name: | Clonixin |
Synonyms: | Clonixin |
Molecular Formula: | C13H11ClN2O2 |
SMILES: | CC1=C(NC2=C(C=CC=N2)C(O)=O)C=CC=C1Cl |
Structure: |
|
DrugBank Description: | Clonixin is a non-steroidal anti-inflammatory drug. |
CAS Number: | 17737-65-4 |
Molecular Weight: | 262.69 |
DrugBank Indication: | Indicated for use in the management of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. |
DrugBank Pharmacology: | Clonixin is a non-steroidal anti-inflammatory drug (NSAID) similar in structure to . It produces vasodilation and analgesia. |
DrugBank MoA: | The mechanism of clonixin does not appear to have been investigated on a molecular level. It is presumed to function similarly to other NSAIDs by inhibiting cycloxygenase enzymes 1 and 2 resulting in a reduction in prostaglandin production. |
Targets: | -- |
Inclusion Criteria: | Therapeutic strategy associated |

Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs | |
---|---|---|---|---|---|
S05 | Anti-inflammatory | inflammatory | Bile acid; TNF-a inhibitor; Dual PPAR-α and -δ agonists; Toll-Like Receptor; (TLR)-4 antagonist; Caspase inhibitor; ASK-1 inhibitor | Ursodeoxycholic Acid; Pentoxifylline; Elafibranor; JKB-121; Emricasan; Selonsertib; | Details |
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Diseases ID | DO ID | Disease Name | Definition | Class |
---|